The impact of low subcutaneous fat in patients with nontuberculous mycobacterial lung disease

Lung

Volumn 192, Issue 3, 2014, Pages 395-401

  Lee, Seok Jeong ^a   Ryu, Yon Ju ^a   Lee, Jin Hwa ^a   Chang, Jung Hyun ^a   Shim, Sung Shine ^b  

^a Ewha Womans University   (South Korea)

^b Ewha Womans University School of Medicine   (South Korea)

Author keywords

Computed X ray tomography; Disease susceptibility; Lung diseases; Nontuberculous mycobacteria; Subcutaneous fat

Indexed keywords

ADULT; AGED; ARTICLE; ATYPICAL MYCOBACTERIUM; BACTERIAL LOAD; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; FEMALE; FOLLOW UP; HUMAN; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM AVIUM; MYCOBACTERIUM INTRACELLULARE; MYCOBACTERIUM KANSASII; NONTUBERCULOUS MYCOBACTERIA LUNG DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPUTUM; SUBCUTANEOUS FAT; HOST PATHOGEN INTERACTION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; OBESITY; PATHOGENICITY; PATHOPHYSIOLOGY; RADIOGRAPHY; RESPIRATORY TRACT INFECTIONS; RISK FACTOR;

ADIPOSITY; AGED; DISEASE SUSCEPTIBILITY; FEMALE; HOST-PATHOGEN INTERACTIONS; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; NONTUBERCULOUS MYCOBACTERIA; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SPUTUM; SUBCUTANEOUS FAT; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84901281891     PISSN: 03412040     EISSN: 14321750     Source Type: Journal    
DOI: 10.1007/s00408-014-9565-x     Document Type: Article

References (34)

1. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ Jr, Winthrop K; ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America (2007) An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacteria diseases. Am J Respir Crit Care Med 175(4):367-416
2. Marras TK, Chedore P, Ying AM, Jamieson F (2007) Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997-2003. Thorax 62(8):661-666 (Pubitemid 47235003)
3. Falkinham JO 3rd (2002) Nontuberculous mycobacteria in the environment. Clin Chest Med 23(3):529-551
4. Aksamit TR (2002) Mycobacterium avium complex pulmonary disease in patients with pre-existing lung disease. Clin Chest Med 23(3):643-653
5. Olivier KN, Weber DJ, Wallace RJ Jr, Faiz AR, Lee JH, Zhang Y, Brown-Elliot BA, Handler A, Wilson RW, Schechter MS, Edwards LJ, Chakraborti S, Knowles MR, Nontuberculous Mycobacteria in Cystic Fibrosis Study Group (2003) Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med 167(6):828-834. doi:10.1164/rccm.200207-678OC (Pubitemid 36801769)
6. Reich JM, Johnson RE (1992) Mycobacterium avium complex pulmonary disease presenting as an isolated lingular or middle lobe pattern. The Lady Windermere syndrome. Chest 101(6):1605-1609
7. Dhillon SS, Watanakunakorn C (2000) Lady Windermere syndrome: middle lobe bronchiectasis and Mycobacterium avium complex infection due to voluntary cough suppression. Clin Infect Dis 30(3):572-575. doi:10.1086/313726 (Pubitemid 30205306)
8. Prince DS, Peterson DD, Steiner RM, Gottlieb JE, Scott R, Israel HL, Figueroa WG, Fish JE (1989) Infection with Mycobacterium avium complex in patients without predisposing conditions. N Engl J Med 321(13):863-868. doi:10.1056/NEJM198909283211304 (Pubitemid 19238618)
9. Kim RD, Greenberg DE, Ehrmantraut ME, Guide SV, Ding L, Shea Y, Brown MR, Chernick M, Steagall WK, Glasgow CG, Lin J, Jolley C, Sorbara L, Raffeld M, Hill S, Avila N, Sachdev V, Barnhart LA, Anderson VL, Claypool R, Hilligoss DM, Garofalo M, Fitzgerald A, Anaya-O'Brien S, Darnell D, DeCastro R, Menning HM, Ricklefs SM, Porcella SF, Olivier KN, Moss J, Holland SM (2008) Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome. Am J Respir Crit Care Med 178(10):1066-1074. doi:10.1164/rccm.200805-686OC
10. Chan ED, Iseman MD (2010) Slender, older women appear to be more susceptible to nontuberculous mycobacterial lung disease. Gender Med 7(1):5-18. doi:10.1016/j.genm.2010.01.005
11. Ikegame S, Maki S, Wakamatsu K, Nagata N, Kumazoe H, Fujita M, Nakanishi Y, Kawasaki M, Kajiki A (2011) Nutritional assessment in patients with pulmonary nontuberculous mycobacteriosis. Intern Med 50(21):2541-2546
12. Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999 (2000). Am J Respir Crit Care Med 161(4):1376-1395. doi:10.1164/ajrccm.161.4.16141
13. Iseman MD, Buschman DL, Ackerson LM (1991) Pectus excavatum and scoliosis. Thoracic anomalies associated with pulmonary disease caused by Mycobacterium avium complex. Am Rev Respir Dis 144(4):914-916
14. Nevill AM, Winter EM, Ingham S, Watts A, Metsios GS, Stewart AD (2010) Adjusting athletes' body mass index to better reflect adiposity in epidemiological research. J Sports Sci 28(9):1009-1016
15. Yuksel I, Sencan M, Dokmetas HS, Dokmetas I, Ataseven H, Yonem O (2003) The relation between serum leptin levels and body fat mass in patients with active lung tuberculosis. Endocr Res 29(3):257-264 (Pubitemid 37176585)
16. Kartalija M, Ovrutsky AR, Bryan CL, Pott GB, Fantuzzi G, Thomas J, Strand MJ, Bai X, Ramamoorthy P, Rothman MS, Nagabhushanam V, McDermott M, Levin AR, Frazer-Abel A, Giclas PC, Korner J, Iseman MD, Shapiro L, Chan ED (2013) Patients with nontuberculous mycobacterial lung disease exhibit unique body and immune phenotypes. Am J Respir Crit Care Med 187(2):197-205
17. van den Borst B, Gosker HR, Koster A, Yu B, Kritchevsky SB, Liu Y, Meibohm B, Rice TB, Shlipak M, Yende S, Harris TB, Schols AM (2012) The influence of abdominal visceral fat on inflammatory pathways and mortality risk in obstructive lung disease. Am J Clin Nutr 96(3):516-526
18. van den Borst B, Gosker HR, Schols AM (2013) Central fat and peripheral muscle: partners in crime in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 187(1):8-13
19. Furutate R, Ishii T, Wakabayashi R, Motegi T, Yamada K, Gemma A, Kida K (2011) Excessive visceral fat accumulation in advanced chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 6:423-430
20. Cnop M, Landchild MJ, Vidal J, Havel PJ, Knowles NG, Carr DR, Wang F, Hull RL, Boyko EJ, Retzlaff BM, Walden CE, Knopp RH, Kahn SE (2002) The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartments. Diabetes 51(4):1005-1015 (Pubitemid 34438343)
21. Borkan GA, Gerzof SG, Robbins AH, Hults DE, Silbert CK, Silbert JE (1982) Assessment of abdominal fat content by computed tomography. Am J Clin Nutr 36(1):172-177 (Pubitemid 12000247)
22. Saelens BE, Seeley RJ, van Schaick K, Donnelly LF, O'Brien KJ (2007) Visceral abdominal fat is correlated with whole-body fat and physical activity among 8-year-old children at risk of obesity. Am J Clin Nutr 85(1):46-53 (Pubitemid 46067614)
23. Ackland TR, Lohman TG, Sundgot-Borgen J, Maughan RJ, Meyer NL, Stewart AD, Muller W (2012) Current status of body composition assessment in sport: review and position statement on behalf of the ad hoc research working group on body composition health and performance, under the auspices of the IOC. Medical Commission. Sports Med 42(3):227-249
24. Liu X, Ji Y, Chen J, Li S, Luo F (2009) Circulating visfatin in chronic obstructive pulmonary disease. Nutrition 25(4):373-378
25. Ryu YJ, Lee JH, Chun EM, Chang JH, Shim SS (2011) Clinical outcomes and prognostic factors in patients with tuberculous destroyed lung. Int J Tuberculosis Lung Dis 15(2):246-250
26. Okumura M, Iwai K, Ogata H, Ueyama M, Kubota M, Aoki M, Kokuto H, Tadokoro E, Uchiyama T, Saotome M, Yoshiyama T, YoshimoriK,YoshidaN, AzumaA,Kudoh S (2008)Clinical factors on cavitary and nodular bronchiectatic types in pulmonary Mycobacterium avium complex disease. Intern Med 47(16):1465-1472
27. Tasaka S, Hasegawa N, Nishimura T, Yamasawa W, Kamata H, Shinoda H, Kimizuka Y, Fujiwara H, Hirose H, Ishizaka A (2010) Elevated serum adiponectin level in patients with Mycobacterium avium-intracellulare complex pulmonary disease. Respiration 79(5):383-387
28. Klein S, Coppack SW, Mohamed-Ali V, Landt M (1996) Adipose tissue leptin production and plasma leptin kinetics in humans. Diabetes 45(7):984-987 (Pubitemid 26225518)
29. Van Harmelen V, Reynisdottir S, Eriksson P, Thorne A, Hoffstedt J, Lonnqvist F, Arner P (1998) Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes 47(6):913-917 (Pubitemid 28255665)
30. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S et al (1995) Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1(11):1155-1161
31. Lord GM, Matarese G, Howard JK, Bloom SR, Lechler RI (2002) Leptin inhibits the anti-CD3-driven proliferation of peripheral blood T cells but enhances the production of proinflammatory cytokines. J Leukocyte Biol 72(2):330-338
32. De Rosa V, Procaccini C, Cali G, Pirozzi G, Fontana S, Zappacosta S, La Cava A, Matarese G (2007) A key role of leptin in the control of regulatory T cell proliferation. Immunity 26(2):241-255 (Pubitemid 46329441)
33. Wieland CW, Florquin S, Chan ED, Leemans JC, Weijer S, Verbon A, Fantuzzi G, van der Poll T (2005) Pulmonary Mycobacterium tuberculosis infection in leptin-deficient ob/ob mice. Int Immunol 17(11):1399-1408 (Pubitemid 41631316)
34. Wolf AM, Wolf D, Rumpold H, Enrich B, Tilg H (2004) Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun 323(2):630-635 (Pubitemid 39221142)